Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Moderate | NA |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.16 | 1.74 |
NAV | ₹58.65 | ₹82.07 |
Fund Started | 27 Apr 2004 | 17 Nov 2003 |
Fund Size | ₹173.25 Cr | ₹3406.09 Cr |
Exit Load | - | Exit load for units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 9.79% | 7.05% |
3 Year | 11.37% | 12.32% |
5 Year | 9.82% | 12.32% |
1 Year
3 Year
5 Year
Equity | 13.82% | 20.96% |
Cash | 7.19% | 3.94% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 1.77% |
ICICI Bank Ltd. | 1.28% |
Kotak Mahindra Bank Ltd. | 0.93% |
SBI Life Insurance Company Ltd. | 0.72% |
Cipla Ltd. | 0.67% |
Mahindra & Mahindra Ltd. | 0.66% |
Hero Motocorp Ltd. | 0.64% |
ITC Ltd. | 0.62% |
NTPC Ltd. | 0.58% |
Samvardhana Motherson International Ltd. | 0.57% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 2.50% |
HDFC Bank Ltd. | 2.00% |
State Bank of India | 1.19% |
Axis Bank Ltd. | 1.14% |
Reliance Industries Ltd. | 1.04% |
Infosys Ltd. | 0.78% |
Larsen & Toubro Ltd. | 0.76% |
Bharti Airtel Ltd. | 0.76% |
ITC Ltd. | 0.74% |
Sun Pharmaceutical Industries Ltd. | 0.74% |
Name | Shantanu Godambe | Dhruv Muchhal |
Start Date | 01 Jan 2025 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate attractive return, consistent with prudent risk, from a portfolio comprising substantially of quality debt securities. It also aims to generate capital appreciation by investing up to 10 per cent its corpus in equity of 100 largest corporates by market capitalization, listed in India. | The scheme seeks to generate income/capital appreciation by investing primarily in debt securities, money market instruments and moderate exposure to equities. |
Launch Date | 27 Apr 2004 | 17 Nov 2003 |
Description
Launch Date